Currently out of the existing stock ratings of David Toung, 135 are a BUY (91.22%), 13 are a HOLD (8.78%).

David Toung

Work Performance Price Targets & Ratings Chart

Analyst David Toung, currently employed at ARGUS, carries an average stock price target met ratio of 73.54% that have a potential upside of 22.85% achieved within 367 days.

David Toung’s has documented 288 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on HOLX, Hologic at 18-Sep-2025.

Wall Street Analyst David Toung

Analyst best performing recommendations are on ISRG (INTUITIVE SURGICAL).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 10/31/2023. The price target of $310 was fulfilled within 20 days with a profit of $47.78 (18.22%) receiving and performance score of 9.11.

Average potential price target upside

of $63.45 (14.86%) on TMO (THERMO FISHER SCIENTIFIC).
of $55.08 (29.24%) on AMGN (AMGEN).
of $51.55 (22.21%) on LLY (ELI LILLY AND COMPANY).

MDT Medtronic PLC MRK Merck mpany TECH Bio-Techne Corp TMO Thermo Fisher Scientific ZBH Zimmer Biomet Holdings ABBV AbbVie ABC AmerisourceBergen BDX Becton Dickinson and Company CRL Charles River Laboratories CTLT Catalent HUM Humana ISRG Intuitive Surgical MCK McKesson UNH UnitedHealth Group BMY Bristol-Myers Squibb Company CELG Celgene GILD Gilead Sciences HOLX Hologic AZN AstraZeneca PLC ADR LLY Eli Lilly and Company PFE Pfizer SILK Silk Road Medical SYK Stryker AMGN Amgen DHR Danaher HCA HCA Holdings CAH Cardinal Health ABT Abbott Laboratories AGN Allergan plc ELV Elevance Health JNJ Johnson & Johnson IART Integra LifeSciences Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Rick Wise (STIFEL)